The presymptomatic stages of frontotemporal dementia (FTD) are still poorly defined and encompass a long accrual of progressive biological (preclinical) and then clinical (prodromal) changes, antedating the onset of dementia. The heterogeneity of clinical presentations and the different neuropathological phenotypes have prevented a prior clear description of either preclinical or prodromal FTD. Recent advances in therapeutic approaches, at least in monogenic disease, demand a proper definition of these predementia stages. It has become clear that a consensus lexicon is needed to comprehensively describe the stages that anticipate dementia. The goal of the present work is to review existing literature on the preclinical and prodromal phases of FTD, providing recommendations to address the unmet questions, therefore laying out a strategy for operationalizing and better characterizing these presymptomatic disease stages.

Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia / Benussi A., Alberici A., Samra K., Russell L.L., Greaves C.V., Bocchetta M., Ducharme S., Finger E., Fumagalli G., Galimberti D., Jiskoot L.C., Le Ber I., Masellis M., Nacmias B., Rowe J.B., Sanchez-Valle R., Seelaar H., Synofzik M., Rohrer J.D., Borroni B., Afonso S., Almeida M.R., Anderl-Straub S., Andersson C., Antonell A., Archetti, S., Arighi A., Balasa M., Barandiaran M., Bargalló N., Bartha R., Bender B., Bertoux M., Bertrand A., Bessi V., Black S., Borrego-Ecija S., Bouzigues A., Bras J., Brice A., Bruffaerts R., Butler C.R., Camuzat A., Cañada M., Cantoni V., Caroppo P., Cash D., Castelo-Branco M., Colliot O., Convery R., Cope T., Danek A., de Mendonça A., Deramecourt V., Di Fede G., Díez A., Duro D., Fenoglio C., Ferrari C., Ferreira C.B., Fox N., Freedman M., Funkiewiez A., Gabilondo, A., Gauthier, S., Gazzina, S., Gerhard, A., Giaccone, G., Gorostidi, A., Graff, C., Guerreiro, R., Heller, C., Hoegen, T., Indakoetxea, B., Jelic, V., Karnath, H.-O., Keren, R., Kuchcinski, G., Laforce, R., Waldo, M.L., Langheinrich, T., Lebouvier, T., Leitão, M.J., Levin, J., Lladó, A., Lombardi G., Lombardi, J., Loosli, S., Maruta, C., Mead, S., Meeter, L., Miltenberger, G., van Minkelen, R., Mitchell, S., Moore, K., Moreno, F., Nelson, A., Nicholas, J., Öijerstedt, L., Olives, J., Otto, M., Ourselin, S., Panman, J., Papma, J.M., Pasquier, F., Pijnenburg, Y., Polito, C., Premi, E., Prioni, S., Prix, C., Rademakers, R., Redaelli, V., Rinaldi, D., Rittman, T., Rogaeva, E., Rollin, A., Rosa-Neto, P., Rossi, G., Rossor, M., Santana, I., Santiago, B., Saracino, D., Sayah, S., Scarpini, E., Schönecker, S., Schroeter, M., Shafei, R., Shoesmith, C., Sorbi S., Swift, I., Tábuas-Pereira, M., Pijnenburg, Y., Tagliavini, F., Tainta, M., Taipa, R., Tang-Wai, D., Tartaglia, C., Thomas, D.L., Thompson, P., Thonberg, H., Timberlake, C., Tiraboschi, P., Todd, E., Van Damme, P., Vandenberghe, R., Vandenbulcke, M., van Swieten, J.C., Veldsman, M., Verdelho, A., Villanua, J., Warren, J., Wilke, C., Woollacott, I., Wlasich, E., Zetterberg, H., Zulaica, M., GENFI Consortium. - In: ALZHEIMER'S & DEMENTIA. - ISSN 1552-5260. - ELETTRONICO. - 18:(2022), pp. 1408-1423. [10.1002/alz.12485]

Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia

Nacmias B.;Bessi V.;Ferrari C.;Lombardi G.;Sorbi S.;
2022

Abstract

The presymptomatic stages of frontotemporal dementia (FTD) are still poorly defined and encompass a long accrual of progressive biological (preclinical) and then clinical (prodromal) changes, antedating the onset of dementia. The heterogeneity of clinical presentations and the different neuropathological phenotypes have prevented a prior clear description of either preclinical or prodromal FTD. Recent advances in therapeutic approaches, at least in monogenic disease, demand a proper definition of these predementia stages. It has become clear that a consensus lexicon is needed to comprehensively describe the stages that anticipate dementia. The goal of the present work is to review existing literature on the preclinical and prodromal phases of FTD, providing recommendations to address the unmet questions, therefore laying out a strategy for operationalizing and better characterizing these presymptomatic disease stages.
18
1408
1423
Benussi A., Alberici A., Samra K., Russell L.L., Greaves C.V., Bocchetta M., Ducharme S., Finger E., Fumagalli G., Galimberti D., Jiskoot L.C., Le Ber I., Masellis M., Nacmias B., Rowe J.B., Sanchez-Valle R., Seelaar H., Synofzik M., Rohrer J.D., Borroni B., Afonso S., Almeida M.R., Anderl-Straub S., Andersson C., Antonell A., Archetti, S., Arighi A., Balasa M., Barandiaran M., Bargalló N., Bartha R., Bender B., Bertoux M., Bertrand A., Bessi V., Black S., Borrego-Ecija S., Bouzigues A., Bras J., Brice A., Bruffaerts R., Butler C.R., Camuzat A., Cañada M., Cantoni V., Caroppo P., Cash D., Castelo-Branco M., Colliot O., Convery R., Cope T., Danek A., de Mendonça A., Deramecourt V., Di Fede G., Díez A., Duro D., Fenoglio C., Ferrari C., Ferreira C.B., Fox N., Freedman M., Funkiewiez A., Gabilondo, A., Gauthier, S., Gazzina, S., Gerhard, A., Giaccone, G., Gorostidi, A., Graff, C., Guerreiro, R., Heller, C., Hoegen, T., Indakoetxea, B., Jelic, V., Karnath, H.-O., Keren, R., Kuchcinski, G., Laforce, R., Waldo, M.L., Langheinrich, T., Lebouvier, T., Leitão, M.J., Levin, J., Lladó, A., Lombardi G., Lombardi, J., Loosli, S., Maruta, C., Mead, S., Meeter, L., Miltenberger, G., van Minkelen, R., Mitchell, S., Moore, K., Moreno, F., Nelson, A., Nicholas, J., Öijerstedt, L., Olives, J., Otto, M., Ourselin, S., Panman, J., Papma, J.M., Pasquier, F., Pijnenburg, Y., Polito, C., Premi, E., Prioni, S., Prix, C., Rademakers, R., Redaelli, V., Rinaldi, D., Rittman, T., Rogaeva, E., Rollin, A., Rosa-Neto, P., Rossi, G., Rossor, M., Santana, I., Santiago, B., Saracino, D., Sayah, S., Scarpini, E., Schönecker, S., Schroeter, M., Shafei, R., Shoesmith, C., Sorbi S., Swift, I., Tábuas-Pereira, M., Pijnenburg, Y., Tagliavini, F., Tainta, M., Taipa, R., Tang-Wai, D., Tartaglia, C., Thomas, D.L., Thompson, P., Thonberg, H., Timberlake, C., Tiraboschi, P., Todd, E., Van Damme, P., Vandenberghe, R., Vandenbulcke, M., van Swieten, J.C., Veldsman, M., Verdelho, A., Villanua, J., Warren, J., Wilke, C., Woollacott, I., Wlasich, E., Zetterberg, H., Zulaica, M., GENFI Consortium
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2158/1281778
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 6
social impact